Developmental Changes in Guanine Nucleotide Regulatory Proteins in the Rat Myocardial Qfi-Adrenergic Receptor Complex
Hyung-Mee Han, Richard B. Robinson, John P. Bilezikian, and Susan F. Steinberg T he action of a r adrenergic agonists to modulate autonomic responsiveness in the heart is dependent on the stage of cardiac development. '-3 In the newborn heart a r agonist stimulation increases automaticity, whereas in the adult heart a,-agonist stimulation reduces automaticity. Sympathetic innervation is implicated in the developmental change of the a r adrenergic chronotropic response from positive to negative. Primary cultures of neonatal rat ventricular myocytes express an exclusive positive a,-adrenergic chronotropic response, whereas myocytes cocultured with and innervated by sympathetic neurons (nerve-muscle cocultures) express a predominantly negative chronotropic response. 3 Binding of agonist to its receptor promotes the coupling of the receptor to an appropriate guanine nucleotide regulatory (G) protein. The agonistreceptor-G protein complex is characterized by highaffinity agonist binding. Binding of GTP, or a suitable analogue, to the G protein leads to reduction in the agonist affinity, reflecting dissociation of the highaffinity agonist-receptor-G protein complex. 4 -5 These actions of GTP to reduce agonist binding affinity reflect influence of a G protein on agonist-receptor interaction. Certain bacterial toxins are also able to modify the affinity of the receptor for agonists. Specifically, pertussis toxin (PT) ADP-ribosylates certain G proteins and, in doing so, interferes with the ability of these G proteins to couple to receptors. 6 To the extent that a particular PT-sensitive G protein is functionally related to a hormone receptor com-plex, exposure to PT will reduce agonist binding affinity to the receptor. In addition, the functional linkage of that G protein to the effector response will be inhibited by PT.
Our previous studies have demonstrated that the a^-adrenergic positive chronotropic response of cultured neonatal rat ventricular myocytes is not modified by PT. In contrast, the a^-adrenergic negative chronotropic response of nerve-muscle cocultures is abolished by PT, suggesting changes in the G protein linkage to the cardiac a r adrenergic receptor induced by innervation. 7 Similar experiments have not been performed in intact rat myocardial tissue. Accordingly, this study was designed in part for assessment of the action of PT in intact neonatal and adult rat hearts after in vivo administration. Additionally, by use of radioligand binding techniques the possibility of developmental changes in G protein linkage of the a r adrenergic receptor in rat myocardium was examined. Although previous functional studies have implicated the coupling of aj-adrenergic receptors to a PT-sensitive G protein in innervated tissues such as rat nerve-muscle cocultures 7 and adult canine Purkinje fibers, 8 there is a lack of information regarding the mechanism of signal transduction at the aj-adrenergic receptor in noninnervated tissue such as neonatal rat heart. The fact that PT did not alter the a,-adrenergic positive chronotropy in pure muscle cultures 7 does not rule out the possibility of coupling of a r adrenergic receptors to a PT-insensitive G protein in neonatal rat heart. An effect of guanine nucleotides for modulation of a^-agonist binding affinity would constitute the first direct evidence for an interaction between the a t -adrenergic catecholamine receptor and a G protein in neonatal mammalian cardiac tissue. 
Materials and Methods

Administration of Pertussis Toxin to Rats
Adult male Wistar rats (250-300 g) were injected intravenously with PT (5-60 Mg/kg body wt) or saline and sacrificed 3 days later. Since it was technically impossible to administer PT intravenously to the neonate, neonatal Wistar rats (0-1 day old) were injected subcutaneoush/ with PT (30-150 /ig/kg body wt) or saline and sacrificed 2 days after treatment.
Preparation of Membranes From Intact Animals
Membranes from control and PT-treated neonatal and adult rat hearts were prepared according to Colucci et al 9 with modifications. Rats were decapitated, and the hearts were placed in ice-cold phosphate-buffered saline (pH 7.4) containing 1 mM ethylenediaminetetraacetate (EDTA) and 0.1 mM phenylmethylsulfonyl fluoride (PMSF). After removal of the atria and great vessels, the ventricles were transferred to a buffer containing sucrose 0.25 M, histidine 0.03 M, EDTA 1 mM, and PMSF 0.1 mM (pH 7.4) and homogenized twice with a polytron (Brinkman Instruments, Westbury, New York) at speed 8 for 10 seconds. The crude homogenate was centrifuged at 1,50% for 15 minutes for removal of large tissue fragments, nuclear debris, and cellular organelles. The supernatant was centrifuged at 43,000g for 15 minutes and resuspended in the assay buffer (50 mM Tris HC1, 10 mM MgCl 2 , 1 ^M ascorbic acid, 1 mM EDTA, and 0.1 mM PMSF, pH 7.5) at a concentration of 2-3 mg protein/ml. The average membrane yield was approximately 0.5% of the initial wet tissue weight. Membranes prepared in this manner were stored at -80° C and used within 2 weeks.
Preparation of Membranes From Neonatal Myocardial Cell Cultures
Myocardial cultures from the ventricles of 1-to 2-day-old Wistar rats were prepared as described previously. 3 Ten milliliters of cell suspension (500,000 cells/ml) was plated in 100 -mm dishes, each precoated with protamine sulfate (1 mg/ml) for 45 minutes. The medium was removed and fresh medium added on day 1 and day 4. On day 4, cultures were treated with either 100 ng/ml PT or saline. After 24 hours, the medium was removed and the cell-detaching medium containing (mmol/1) NaCl 130, NaHCO 3 16, KC1 3, NaH 2 PO 4 0.5, sucrose 10, and EDTA 1 was added. After 30 minutes, cells were removed by scraping with a rubber policeman and collected in a buffer containing sucrose 0.25 M, histidine 0.03 M, EDTA 1 mM, and PMSF 0.1 mM (pH 7.4). Membranes were prepared as described above.
Binding of [ l2i I]-IBE 2254 to Myocardial Membranes
BE 2254 was iodinated according to Engel and Hoyer, 10 and binding was performed as previously described. 11 Briefly, [ 125 I]-IBE 2254 (60 pM) was incubated with myocardial membranes (60 fig) in a final volume of 1 ml for 30 minutes at 30° C. The assay buffer contained Tris HC1 50 mM, MgCl 2 10 mM, ascorbic acid 1 jiM, EDTA 1 mM, and PMSF 0.1 mM (pH 7.5). The assay was terminated by dilution with 1 ml ice-cold assay buffer and immediate vacuum filtration of the entire assay volume through A/E glass fiber filters (Gelman Sciences, Ann Arbor, Michigan), followed by one wash with 10 ml ice-cold assay buffer. Nonspecific binding, defined as that component of total binding not inhibited by either 1 mM 1-epinephrine or 1 pM prazosin, was usually less than 10% of total binding. Samples were counted in an auto-gamma scintillation spectrometer (Packard Instrument, Downers Grove, Illinois) with a precision of three significant figures based on repetitive measurements of a test sample. Consequently, all tabulated data are expressed to three significant figures.
l n P]ADP-Ribosylation by Pertussis Toxin
The [ 32 P]ADP-ribosylation assay was performed as described previously. 7 PTwas activated by incubation with 10 mM dithiothreitol for 10 minutes at 30° C. Twenty-five microliters (25 ng protein) of membranes was incubated in 65 /AI buffer containing 50 mM K^PCX,, 10 units aprotinin, 200 piM GTP, 20 mM thymidine, 5 mM ADP-ribose, 20 mM arginine, 2-6 fjM [ 32 P]-NAD (19-58 Ci/mmol), and 2.5 y% PT for 20 minutes at 30° C. The reaction was terminated by the addition of 1 ml ice-cold 7% trichloroacetic acid and centrifugation at 27,000g. The pellet was resuspended in 1% trichloroacetic acid, recentrifuged at 27,000g, and solubilized with sodium dodecyl sulfate sample buffer. Electrophoresis was performed on slab gels (main gel 9%; stacking gel 3% acrylamide) at 300 V for 3 hours. The gels were then visualized with Coomassie blue and autoradiography using XRP-5 film (Eastman Kodak, Rochester, New York). The specific protein band on the polyacrylamide gel that coincided with the labeled band on the autoradiogram was excised and counted by use of liquid scintillation spectroscopy. ADPribosylation reactions were performed in the absence and presence of 0.1% Lubrol. 
Measurement of Pharmacological Responsiveness of Intact Tissues
Control and PT-treated neonatal and adult rats were decapitated. The hearts were quickly removed and placed in ice-cold Tyrode's solution containing (mmol/1) NaCl 131, NaHCOj 18, CaCl 2 2.7, MgCl 2 0.5, NaH 2 P0< 1.8, KC1 4, and dextrose 5.5 (pH 7.4) and gassed with 95% Oj/5% COj. The interventricular septum was dissected from the rest of the heart. Care was taken to avoid instrument contact with any part of the interventricular septum that would be used in the experiments. The adult preparation was further trimmed from one side of the septum (usually from the right ventricular side) until its thickness reached approximately 1 mm. The interventricular septum was then mounted on a Lucite chamber (volume 3 ml). The tissue was superfused with Tyrode's solution, gassed with 95% O 2 /5% CO 2 , and warmed to 37° C. The flow rate of the perfusate was 10-12 ml/min. The rate of beating was monitored by use of Teflon-coated bipolar silver wire electrodes connected to an AC-coupled amplifier. The signal was recorded on a strip chart recorder. The tissue was allowed to beat spontaneously in the bath for 20 minutes. Those preparations that attained a regular and stable rhythm within this time frame were monitored for an additional 20 minutes for stability before the experiment was started. The effect of phenylephrine on spontaneous rate was assessed by exposure of each preparation to increasing concentrations of phenylephrine (10~9 to 10 5 M) for 10 minutes. The spontaneous rate was determined during the last 2-3 minutes of each concentration. After exposure to the highest concentration of phenylephrine, the preparation was washed with Tyrode's solution to return to the control spontaneous rate. At the end of each experiment, the preparation was stored at -80° C until it was used for preparation of membranes for the ADP-ribosylation assay.
Data Analysis
Equilibrium binding experiments were analyzed according to the method of Scatchard 12 for determination of the equilibrium dissociation constant (K,,) and the number of binding sites ( B^) . Hill coefficients (slope factors) 13 for nonradioactive agonist competing for the radioligand-binding sites were calculated from the slope of a plot of log [%B/ (100-%B)] versus log [nonradioactive agonist], where %B is the percentage of radioligand binding displaced by the competing agonist. Competition binding curves were further analyzed by use of the iterative least-squares curve-fitting program 14 - 15 to test the goodness of the fit of the data to a given model. In each case, one-and two-site analyses were compared by use of an F test; the statistically better fit (/><0.05) is reported in Table 3 . In comparison of the slope factor, B^, and K^ among different groups, one-way analysis of variance (ANOVA) was used, 16 For determination of the difference in means between two groups, multiple comparisons by use of the Bonferroni modified t test were applied, 17 and the differences in mean values at the/?<0.05 level were considered significant. All pharmacological responsiveness curves were analyzed by nested ANOVA, 18 and significant differences were determined at the /?<0.05 level. Differences in mean values at thep<0.05 level were determined by use of the Bonferroni critical value for the modified t test.
Results
Binding of [ m I]-lBE 2254 to Neonatal and Adult Rat Myocardial Membranes
Characteristics of a,-adrenergjc binding were examined in the context of the changing a,-adrenergic 
Exposure of Rats In Vivo to Pertussis Toxin
The next set of questions required a protocol for in vivo PT administration that would effectively ADP-ribosylate and inactivate the myocardial PTsensitive G protein. Accordingly, neonatal and adult rats were injected with a range of concentrations of PT. In vitro [ PT substrate. Therefore, these concentrations were employed in subsequent experiments. The apparent difference in the sensitivity to in vivo PT administration between neonates and adults was at least in part due to differences in the routes of administration (subcutaneous in neonates versus intravenous ]-IBE 2254 were identical in these membranes, indicating that PT has no effect on the a,-adrenergic receptor-antagonist interaction (Table 1) .
Pharmacological Responsiveness
The functional consequences of in vivo ADPribosylation by PT were evaluated by determination of the a,-adrenergic chronotropic response of interventricular septa prepared from neonatal and adult rat hearts. The aim of these experiments was for determination of whether the in vivo PT-treatment protocol inactivated a sufficient quantity of the PT-sensitive G protein in the adult so as to interfere with signal transduction and thereby abolish a r adrenergic-dependent negative chronotropy. The experiment was also designed for examination of whether in vivo PT administration had any effect on a,-adrenergic-mediated positive chronotropy in the neonatal rat. Control beating rates of interventricular septa from vehicle-or PT-treated animals were not significantly different from each other.
In agreement with previously reported results, 3 the a r adrenergic agonist phenylephrine (1(T 8 M) induced an increase in beating rate in neonatal interventricular septal preparations from 90 ±10 to 112±11 beats/min ( Figure 3A) . The a,-adrenergicmediated positive chronotropic response was similar in vehicle-and PT-treated preparations. In contrast, as shown in Figure 3B , 10~8 M phenylephrine decreased the automatic beating rate in the adult septum from 90 ±12 to 69 ±10 beats/min (n=l, p<0.05). This a,-adrenergic-dependent negative chronotropic response was abolished by prior exposure of adult rats to 30 fig/kg PT in vivo; after PT administration, 10" 8 M phenylephrine significantly increased the beating rate from 84±17 to 108±17 beats/min (n = 10,p<0.05). Thus, a similar degree of in vivo ADP-ribosylation by PT has no effect on the a r adrenergic positive chronotropic response of the neonatal heart but totally eliminates the a r adrenergic negative chronotropic response of the adult heart.
For further examination of the degree of inactivation of PT substrates required for the conversion of the a r adrenergic-mediated chronotropic response from negative to positive in the adult, experiments were performed on interventricular septal preparations from adult rats treated with an intermediate dose of PT (5 /Ag/kg body wt). At this dose of PT, only 26±5% of the PT substrate remained intact based on data obtained from matching ADPribosylation experiments on the same tissue samples. However, as shown in Figure 3B , 10~8 M phenylephrine still induced the negative chronotrop- ic response (from 95 ±12 to 75 ±11 beats/min, p<0.05). The dose-response curves of the control adult and 5-;itg/kg PT-treated adult were not significantly different, as tested by nested ANOVA (p>0.05). Therefore, approximately one quarter of the potentially available PT substrate appears to sufficiently couple a r adrenergic receptors to the effector system so as to achieve the full negative chronotropic response in the adult rat heart.
Effect of Guanine Nucleotides on Agonist Binding to aj-Adrenergic Receptors in Neonatal and Adult Rat Myocardium
One means by which coupling of G proteins to their hormone receptors can be assessed is deter- 
Log[l-Epinephrine] M FIGURE 4. Effect of Gpp(NH)p on competition of l-epinephrine for [ l25 Ij-IBE 2254 binding sites in membranes prepared from control and PT-treated neonatal and adult rat hearts. Heart membranes were incubated with 60pM [ 12i I]-IBE 2254 and increasing concentrations of l-epinephrine in absence or presence of500 pM Gpp(NH)p. Data points are mean of duplicate determinations. Results shown are representative of several such experiments (n=5 for control neonate, n=4 for PT-treated neonate, n=<5 for control adult, n=6 for PT-treated adult). Curves are based on computer analysis of data. PT, pertussis toxin; Gpp(NH)p, 5'-guanyfylimidodiphosphate.
mination of the ability of guanine nucleotides, such as Gpp(NH)p, to reduce agonist-binding affinity. This effect would occur whether or not the G protein is a substrate for PT. In view of the results showing a profound capacity of PT to alter a pharmacological property of a r adrenergic receptors in adult rat myocardium, we anticipated that the PTsensitive G protein associated with the a xadrenergic negative chronotropic response would modulate agonist-binding affinity. We were also interested in examining this issue in the newborn rat heart, which does not have a PT-sensitive pharmacological response. Figure 4A demonstrates a shallow competition curve for l-epinephrine binding to the a,-adrenergic receptor site in neonatal rat myocardial membranes, consistent with a population of a tadrenergic receptors displaying a mixture of affinities for agonists ( Table 2) . As analyzed by nonlinear least-squares curve-fitting analysis, 14 -15 l-epinephrine binding to neonatal rat cardiac membranes conformed to a two-site model (Table 3) . Approximately 19% of the receptor sites displayed highaffinity binding (KH=76 nM), and 81% were in a lower affinity state (1^=1,080 nM). Addition of Gpp(NH)p resulted in a rightward shift and steepening of the agonist competition curve ( Figure 4A , Table 2 ). In the presence of Gpp(NH)p, the 1-epinephrine competition curve was better fit to a one-site model, describing simple binding to a homogeneous population of lower affinity a,-adrenergic receptor sites (1^=2,380 nM, Table 3 ).
In adult heart membranes ( Figure 4B ), a similarly shallow curve described l-epinephrine displacement of [ I25 I]-IBE 2254 binding, suggesting the presence of heterogeneous binding sites ( Table 2) . As in neonatal rat heart membranes, nonlinear least- reduced number of high-affinity sites after treatment with PT. Taken together, these observations suggest that in the adult rat myocardium, the a,-adrenergic receptor is coupled to both a PTsensitive and a PT-insensitive G protein.
Binding of[ l2i I]-IBE 2254 to Membranes Prepared From Neonatal Myocardial Cell Cultures
As shown in Figure 2A , subcutaneous injection of neonatal rats with PT did not lead to 100% endogenous ADP-ribosylation, even when a concentration of up to 150 /xg PT/kg body wt was employed. One could argue that guanine nucleotide modulation of the 1-epinephrine-binding affinity persisted in the neonate after PT treatment due to incomplete inactivation of the PT substrate; that is, the remaining 5% of the PT substrate might be sufficient to couple to the a r adrenergic receptor and generate the high-affinity binding state.
Although it was not possible to completely eliminate the PT substrate in intact animals, complete ADP-ribosylation of the PT substrate by preincubation with PT is possible in neonatal myocardial cell cultures. 7 Therefore, to rule out the possibility that the absence of an effect of PT for modulation of agonist binding in the neonate might be due to incomplete inactivation of the PT substrate, we performed competition binding experiments on membranes prepared from control {s^Krie-tfeafed) and PT-treated (100 ng/m] PT, 24-hour incubation) neonatal rat myocardial cell cultures. As shown in the inset of Figure 6 , this PT-treatment protocol completely inactivated the PT substrate. In this series of experiments, because of the limited tissue availability in cultures, competition binding experiments were performed at only a single l-epinephrine concentration (10~6 M) with and without 500 ^M Gpp-(NH)p. This concentration of l-epinephrine, providing approximately 50% displacement, was chosen to be maximally sensitive to any possible effect of PT on agonist-binding affinity. The increase in the binding of [ 12 5I]-IBE 2254 due to guanine nucleotides, which resulted from the nucleotide-induced decrease in the receptor affinity for the agonist, was determined. As shown in Figure 6 , 10~* M 1-epinephrine caused a comparable displacement in control and PT-treated membranes (55±3% in control membranes; 53±1% in PT-treated membranes, « = 4 in each group, p>0.05, two-tailed t test). The 500 ^iM Gpp(NH)p caused a significant increase in [ 12S I]-IBE 2254 binding in both control and PTtreated membranes, confirming that the a r adrenergic receptor in the neonate is coupled to a PT-insensitive G protein.
Discussion
The experiments presented in this paper have employed in vivo PT administration for examination of the properties of the cr,-adrenergic receptor complex in the neonatal and adult rat heart. The results support and extend our previous observations, 7 and together they indicate that the change in chronotropic responsiveness from positive in the neonate to negative in the adult requires increased coupling of a PT-sensitive G protein to the cardiac aradrenergic receptor during development. In addition, the results demonstrate, in both neonatal and adult rat heart, a G protein linked to the a v adrenergic receptor that does not serve as a substrate for PT.
Guanine nucleotides have been shown to exert regulatory effects on receptors that mediate adenylate cyclase activity and other biochemical effectors. It is now well established that guanine nucleotides are required for both hormonal activation and hormonal inhibition of adenylate cyclase. They are also required for receptor-mediated transducrion of activities mediated by cyclic GMP phosphodiesterase, phosphatidylinositol hydrolysis, and ion channels. 19 They modulate receptor function, in part, by decreasing the affinity of agonist, but not of antagonist, for the receptors to which they are linked. This action of guanine nucleotides is considered as evidence for a molecular interaction between a G protein and a receptor/- 5 Several groups of investigators have provided evidence that the a,-adrenergic receptor is coupled to a G protein in various tissues, 9 -20 -25 although other investigators have been unable to show such regulation.
26
- 27 The inconsistent reports concerning guanine nucleotide modulation of the c^-adrenergic agonist binding affinity by other laboratories may reflect the relatively small effect of guanine nucleotides on the a,-agonist binding affinity (compared with that seen at the /3-adrenergic receptor) and its requirement for specific assay conditions. In particular, inclusion of EDTA and PMSF during the preparation of membranes and in the binding assay may be crucial. 25 Our present data clearly demonstrate that guanine nucleotides can modulate a,-agonist binding affinity in both neonatal and adult rat myocardium, indicating that the a r adrenergic receptor is coupled to a G protein in noth-neonatal and adult rat myocardium. This is the first direct demonstration of a linkage function of a G protein to the a r adrenergic receptor in the neonatal rat myocardium.
The identity of the G protein involved in signal transduction at the a,-adrenergic receptor has been investigated by use of PT, which is known to ADPribosylate and functionally inactivate certain G proteins. The results of these studies are conflicting. 25 Differences in the PT sensitivity of the c^-adrenergic response observed could be due to tissue differences employed in each study or incomplete inactivation of the endogenous PT substrate.
Our results indicate that the myocardial a x adrenergic receptor can couple to both a PTsensitive and a PT-insensitive G protein. Persistent modulation of agonist binding by guanine nucleotides after PT treatment in the neonate indicates that the G protein to which the a j -receptor is coupled in the neonatal rat heart is not a PT substrate. On the other hand, in the adult rat heart, the aj-agonist-induced negative chronotropic response, as well as the effect of guanine nucleotides on agonist binding affinity, are sensitive to PT, indicating that the a r adrenergic receptor in the adult rat myocardium becomes coupled to a PTsensitive G protein. It is noteworthy that although PT significantly reduced the ability of guanine nucleotides to modulate agonist binding in the adult, a residual shift by guanine nucleotides remained after PT treatment. There are several possible explanations for this residual shift by guanine nucleotides in adult myocardium exposed to PT. The in vivo PT treatment protocol effectively ADP-ribosylated and inactivated up to 95% of the PT-sensitive G protein.
However, a small amount (approximately 5%) persisted in the PT-treated myocardium and could be responsible for the residual shift by guanine nucleotides after PT treatment. A more likely interpretation of the data is that the a r adrenergic receptor in the adult rat heart can couple to at least two G proteins, one of which is PT-sensitive and the other PT-insensitive. PT treatment would abolish the coupling_of ai-receptors to a PT-sensitive G protein but would have no effect on the coupling of ar receptors to a PT-insensitive G protein. Thus, the component of guanine nucleotide modulation of the agonist competition binding curve influenced by the PT-insensitive G protein would remain intact after exposure to PT.
Results of this study emphasize the importance of maximal modification of the PT substrate when implicating its involvement in the biological response. In adult rats injected with an intermediate dose of PT (5 /ug/kg), an a,-adrenergic-mediated negative chronotropic response comparable with the response seen in the control myocardium persisted, despite considerable inactivation of the myocardial PT substrate. This would suggest that the PT-sensitive G protein that is coupled to the a,-adrenergic receptor in the adult is present in excess.
Alternatively, there may be several different PTsensitrve G proteins that have differejOt sensitivity to in vivo exposure to PT. The PT>sensitive G protein to which the a,-adrenergic receptor is coupled may be less sensitive to inactivation than the others. Thus, if this particular PT-sensitive G protein is to be inactivated, most of the others may have to be inactivated first.
The identity of the PT-sensitive G protein that is acquired during development is not clear at present. Probable candidates are two known G protein classes that are substrates for PT-dependent ADPribosylation, referred to as G; and G O . 35 Using a clone from rat olfactory neuroepithelium, Jones and Reed 36 reported the expression of three different G ; s in the rat heart. Recently, Luetje ct al 37 demonstrated that the level of expression of the messages for the individual Gj subspecies is regulated differentially with development in the rat heart. Obviously, much more work needs to be done to determine which PT-sensitive G protein becomes coupled to the aj-adrenergic receptor during development. In addition, other developmentally regulated mechanisms distal to the G protein also may be required for the expression of the mature c^-adrenergic negative chronotropic response.
The coincidence in the neonate between the presence of a PT-insensitive G protein linked to the a r receptor and the a^-adrenergic-mediated positive chronotropic response raises the possibility that this response is mediated by a PT-insensitive G protein. 38 ' 39 Recent studies have demonstrated a role for a PT-insensitive G protein in the linkage of the a,-receptor to inositol trisphosphate accumulation in myocardial cells (Steinberg et al, unpublished observation) . This finding may suggest that a r adrenergic activation of inositol phospholipid metabolism via a PT-insensitive G protein underlies a r adrenergic positive chronotropy. In addition, in the PT-treated adult, there is an «i-adrenergicmediated positive chronotropic response and a residual shift by guanine nucleotides. Thus, it is possible that in both the adult and the neonate, a PTinsensitive G protein links the a r adrenergic receptor to a positive chronotropic response. Whether the PT-insensitive G proteins that are coupled to the a r adrenergic receptor in the adult and the neonate are the same remains to be resolved.
